-
Investment Risks and Logic of the Bio-medicine Industry (2)
En-CPhI.cn
May 21, 2019
Characteristics of the bio-medicine industry decide that unique ideas should be employed to invest in the field...
-
Investment Risks and Logic of the Bio-medicine Industry (1)
En-CPhI.cn
May 21, 2019
The development of innovative drugs has made remarkable achievements: there have been 6 innovative drugs marketed since last year, with good news coming one after another.
-
£2m NHS investment into leadership development
pharmatimes
May 12, 2019
NHS England has funded a £2 million programme to help boost system-wide leadership development.
-
Catalent to increase patient-centric dose form manufacturing capabilities at Winchester, Kentucky
cphi-online
May 07, 2019
$40 million investment adds spray drying, stick pack and expanded capabilities in controlled-release tableting and encapsulation.
-
Symic Bio Announces Closing of Investment led by CIP
firstwordpharma
April 26, 2019
SAN FRANCISCO, April 25, 2019 /PRNewswire/ -- Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced the closing of financings led by Cell Innovation Partners (CIP) ...
-
Aidoc raises $27 Million to expand its AI solutions by 700%
biospectrumasia
April 21, 2019
The radiology AI leader will grow its customer base and continue its mission to have AI become standard of care
-
ACG commits to further investment in Brazil
expressbpd
February 20, 2019
ACG Capsules launches a new factory in Pouso Alegre-MG, generating local employment
-
Lucid Group appoints Rob Apollo to its senior leadership team
pharmaphorum
January 16, 2019
Lucid Group has expanded its senior leadership team with the appointment of Rob Apollo as director of corporate development.
-
2018 set benchmark for digital health investment – report
pharmaphorum
January 09, 2019
Last year was the biggest ever for digital health investment, according to a report that has been tracking the market since the beginning of the decade.
-
Bruntwood to make £10M life science investment
pharmatimes
December 20, 2018
Bruntwood SciTech has announced a £10 million investment into the life sciences sector, in the form of 50,000 square feet of office space and laboratory facilities in Alderley Park, Cheshire.